South Australian Health and Medical Research Institute (SAHMRI), Monday, 27 February 2017
South Australians at a high risk of acquiring HIV will have the opportunity to benefit from the latest HIV prevention medication through a new partnership.
Following the announcement of the Pre-Exposure Prophylaxis (PrEP) access trial late last year, Victoria’s Alfred Health has been chosen to partner with the South Australian Health and Medical Research Institute (SAHMRI), SA Health and local clinics for the study to begin in April.
“We want to include people from culturally and linguistically diverse populations and Aboriginal people so that these communities are not adversely affected by HIV,” Professor Wesselingh said.
- Find the PrEPX-SA Study Information Register at www.alfredhealth.org.au/prepxsa or, for further information about the study, contact m: 0429 473 138 e: email@example.com.
- Read announcement – download at the link HIV PREVENTION STUDY TO COMMENCE APRIL 2017_FINAL 270217